Ramesh Hariharan
Corporate Officer/Principal chez NATERA, INC.
Profil
Ramesh Hariharan is currently working as the General Manager-Women's Health at Natera, Inc. Previously, he worked as the Vice President-Marketing at Biotheranostics, Inc. from 2014 to 2016.
Dr. Hariharan holds a doctorate degree from Princeton University, an undergraduate degree from the Indian Institute of Technology Bombay, and an MBA from Mit Solan School of Management.
Postes actifs de Ramesh Hariharan
| Sociétés | Poste | Début |
|---|---|---|
| NATERA, INC. | Corporate Officer/Principal | - |
Anciens postes connus de Ramesh Hariharan
| Sociétés | Poste | Fin |
|---|---|---|
Biotheranostics, Inc.
 Biotheranostics, Inc. Medical/Nursing ServicesHealth Services Biotheranostics, Inc. develops and provides diagnostic, prognostic and predictive tests that support physicians in the treatment of cancer patients. It has commercialized two proprietary, highly differentiated products focused on early stage breast cancer and all metastatic cancers, Breast Cancer Index (BCI) and CancerTYPE ID (CTID). The company was founded by Thomas M. Baer in 2008 and is headquartered in San Diego, CA. | Sales & Marketing | 01/04/2016 |
Formation de Ramesh Hariharan
| Indian Institute of Technology Bombay | Undergraduate Degree |
| Princeton University | Doctorate Degree |
| Mit Solan School of Management | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| NATERA, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Biotheranostics, Inc.
Biotheranostics, Inc. Medical/Nursing ServicesHealth Services Biotheranostics, Inc. develops and provides diagnostic, prognostic and predictive tests that support physicians in the treatment of cancer patients. It has commercialized two proprietary, highly differentiated products focused on early stage breast cancer and all metastatic cancers, Breast Cancer Index (BCI) and CancerTYPE ID (CTID). The company was founded by Thomas M. Baer in 2008 and is headquartered in San Diego, CA. | Health Services |
